fda warning letters compounding semaglutide news warns about safety of 'off-brand' versions of Ozempic, Wegovy FDA issued 25 warning letters

GLP-1s help the kidneys release more sodium into the urine, which reduces fluid buildup in the bloodstream and eases pressure on blood vessels

However, GLP-1 RAs may be considered to lower the CV risk in patients with T2D who have a high to very high risk of CVD, (class IIb, level C)

These drugs didnt come out of nowhere, said Andrew Hardaway, Ph.D., a neuroscientist in the UAB Department of Psychiatry and Behavioral Neurobiology, who studies how hormones influence brain circuits that regulate appetite and reward

By Anne Toole

Importantly, comorbid T2DM or elevated peripheral IR accelerate disease progression in AD and PD independently of vascular disease, with higher peripheral IR predicting conversion from mild cognitive impairment to AD (12, 13) and faster motor and cognitive decline in PD (14, 15), thereby implicating IR as a modifier of NDD biology rather than a simple comorbidity

According to the treatment estimand results, retatrutide resulted in 17.6% (4 mg), 23.7% (9 mg) and 25.0% (12 mg) weight loss across the treatment arms (vs 3.9% with placebo)